12-63569286-T-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_173812.5(DPY19L2):c.2064A>T(p.Lys688Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000924 in 1,601,632 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_173812.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DPY19L2 | NM_173812.5 | c.2064A>T | p.Lys688Asn | missense_variant | 21/22 | ENST00000324472.9 | NP_776173.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DPY19L2 | ENST00000324472.9 | c.2064A>T | p.Lys688Asn | missense_variant | 21/22 | 1 | NM_173812.5 | ENSP00000315988.4 |
Frequencies
GnomAD3 genomes AF: 0.0000657 AC: 10AN: 152108Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000700 AC: 17AN: 242782Hom.: 0 AF XY: 0.0000837 AC XY: 11AN XY: 131350
GnomAD4 exome AF: 0.0000952 AC: 138AN: 1449524Hom.: 0 Cov.: 30 AF XY: 0.0000999 AC XY: 72AN XY: 720688
GnomAD4 genome AF: 0.0000657 AC: 10AN: 152108Hom.: 0 Cov.: 32 AF XY: 0.0000808 AC XY: 6AN XY: 74300
ClinVar
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 06, 2023 | The c.2064A>T (p.K688N) alteration is located in exon 21 (coding exon 21) of the DPY19L2 gene. This alteration results from a A to T substitution at nucleotide position 2064, causing the lysine (K) at amino acid position 688 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at